State Street Corp Myriad Genetics Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, State Street Corp holds 4,703,442 shares of MYGN stock, worth $78.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,703,442
Previous 4,343,757 8.28%
Holding current value
$78.5 Million
Previous $106 Million 21.16%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.97 - $28.6 $8.62 Million - $10.3 Million
359,685 Added 8.28%
4,703,442 $129 Million
Q2 2024

Aug 14, 2024
SELL
$17.98 - $25.47 $19.1 Million - $27 Million
-1,059,928 Reduced 19.61%
4,343,757 $106 Million
Q1 2024

May 15, 2024
BUY
$17.59 - $23.59 $12.4 Million - $16.6 Million
703,054 Added 14.96%
5,403,685 $115 Million
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $246,916 - $378,451
17,751 Added 0.38%
4,700,631 $90 Million
Q3 2023

Nov 14, 2023
SELL
$15.99 - $23.22 $641,326 - $931,307
-40,108 Reduced 0.85%
4,682,880 $75.1 Million
Q2 2023

Aug 14, 2023
BUY
$17.56 - $23.76 $2.11 Million - $2.85 Million
120,069 Added 2.61%
4,722,988 $109 Million
Q1 2023

May 15, 2023
SELL
$15.26 - $23.75 $6.37 Million - $9.92 Million
-417,504 Reduced 8.32%
4,602,919 $107 Million
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $5.27 Million - $7.62 Million
363,160 Added 7.8%
5,020,423 $72.8 Million
Q3 2022

Nov 15, 2022
SELL
$18.21 - $27.88 $2.67 Million - $4.1 Million
-146,894 Reduced 3.06%
4,657,263 $88.9 Million
Q2 2022

Aug 15, 2022
BUY
$16.45 - $25.88 $10 Million - $15.7 Million
607,932 Added 14.49%
4,804,157 $87.3 Million
Q1 2022

May 16, 2022
SELL
$22.67 - $28.01 $4.86 Million - $6 Million
-214,178 Reduced 4.86%
4,196,225 $106 Million
Q4 2021

Feb 14, 2022
BUY
$24.13 - $32.63 $2.79 Million - $3.77 Million
115,570 Added 2.69%
4,410,403 $122 Million
Q3 2021

Nov 15, 2021
BUY
$29.97 - $36.66 $6.16 Million - $7.53 Million
205,528 Added 5.03%
4,294,833 $139 Million
Q2 2021

Aug 16, 2021
BUY
$25.39 - $32.61 $1.39 Million - $1.78 Million
54,648 Added 1.35%
4,089,305 $125 Million
Q1 2021

May 17, 2021
BUY
$19.92 - $31.6 $6.36 Million - $10.1 Million
319,127 Added 8.59%
4,034,657 $123 Million
Q4 2020

Feb 16, 2021
SELL
$12.16 - $19.77 $7.57 Million - $12.3 Million
-622,352 Reduced 14.35%
3,715,530 $73.5 Million
Q3 2020

Nov 10, 2020
SELL
$11.25 - $14.75 $11.7 Million - $15.4 Million
-1,042,716 Reduced 19.38%
4,337,882 $56.6 Million
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $13.7 Million - $21.2 Million
1,284,595 Added 31.36%
5,380,598 $61 Million
Q1 2020

May 11, 2020
BUY
$9.78 - $29.53 $40.1 Million - $121 Million
4,096,003 New
4,096,003 $58.6 Million

Others Institutions Holding MYGN

# of Institutions
254
Shares Held
90.9M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.35B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email